Mini-Focus Issue: Drug TherapyClinical ResearchEffect of Dapagliflozin, Compared With Placebo, According to Baseline Risk in DAPA-HF
Clinical Research
Under a Creative Commons license
open access
Central Illustration
Key Words
heart failure
MAGGIC
PREDICT-HF
prognostic model
risk score
sodium-glucose cotransporter 2 inhibitor
survival
Abbreviations and Acronyms
KCCQ
Kansas City Cardiomyopathy Questionnaire
LVEF
left ventricular ejection fraction
NNT
number needed to treat
NYHA
New York Heart Association
SBP
systolic blood pressure
Cited by (0)
The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors’ institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the Author Center.
© 2022 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.